Geftistar is a brand of tablets manufactured by Lupin Pharmaceuticals Ltd. Each tablet contains 250mg of the active ingredient Gefitinib. It is available in a pack of 100 tablets and requires a prescription from a qualified healthcare professional.
Geftistar is used in the treatment of non-small cell lung cancer (NSCLC) that has a specific genetic mutation called epidermal growth factor receptor (EGFR) mutation. It works by blocking the action of the EGFR protein, which is responsible for the growth and division of cancer cells.
How to use:
Geftistar tablets should be taken orally, with or without food. The dosage and duration of treatment depend on the patient’s condition, weight, and response to the medication. It is important to take the medication exactly as prescribed by your healthcare provider.
Geftistar tablets should be stored in a cool, dry place, away from direct sunlight and heat. It should be kept out of the reach of children and pets.
Mechanism of action:
Gefitinib is a type of targeted therapy that works by inhibiting the activity of the EGFR protein, which is found on the surface of cancer cells. This protein is responsible for the growth and division of cancer cells. By blocking the activity of the EGFR protein, Gefitinib helps to slow down or stop the growth and spread of cancer cells.
Before using Geftistar, it is important to inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking. This medication may cause side effects such as diarrhea, nausea, and skin rash.
Geftistar is contraindicated in individuals who are allergic to Gefitinib or any of the other components of the medication. It should not be used by individuals who are pregnant, breastfeeding, or who have severe liver or kidney problems.
Geftistar can interact with other medications, therefore it is important to inform your healthcare provider about any medications, dietary supplements, or herbal preparations you are taking. Some examples of drugs that can interact with Geftistar include warfarin, phenytoin, and rifampicin.
In case of an overdose, immediate medical attention should be sought. The symptoms of an overdose may include diarrhea, skin rash, and breathing difficulties.
Geftistar tablets may cause some side effects such as diarrhea, nausea, and skin rash. In some cases, it may cause severe side effects such as liver problems, interstitial lung disease, or vision problems. Patients who experience severe side effects while using Geftistar should seek medical attention immediately.